Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 40Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 18Rectal Neoplasms 14Lung Neoplasms 13Stomach Neoplasms 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Esophageal Squamous Cell Carcinoma 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Adenocarcinoma Of Esophagus 8Sarcoma 7Ovarian Neoplasms 7Neoplasms 6Head and Neck Neoplasms 6Urinary Bladder Neoplasms 5Osteosarcoma 5Liver Neoplasms 5Kidney Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Turcot syndrome 3Multiple Myeloma 3Locally Advanced Rectal Cancer 3

Interventions

Carboplatin 2Bevacizumab 2stenoparib 1senaparib 1sargramostim 1olaparib 1liposomal doxorubicin 1Saline Solution 1Paclitaxel 1Neoadjuvant Therapy 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Ovarian Cancer × Neoadjuvant Therapy × Clear all
NCT01462149 2017-05-31

Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer

Asan Medical Center

Phase 2 Completed
43 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡